K
v
ire
.com
←
Back
Night
Docs
Library
Review
…
Author
Marc A. Pfeffer
also known as Lars Kber, M A Pfeffer, M PFEFFER
Brigham and Women's Hospital · Harvard University · Università Cattolica del Sacro Cuore · AstraZeneca (United Kingdom)
About this author
Works
876
Cited by
144,339
h-index
168
i10
548
ORCID ↗
Top papers
The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
Frank M. Sacks, Marc A. Pfeffer, Lemuel A. Moyé, et al.
·
1996
·
New England Journal of Medicine
↗ 7,481
OA
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
Marc A. Pfeffer, Eugene Braunwald, Lemuel A. Moyé, et al.
·
1992
·
New England Journal of Medicine
↗ 5,942
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
Christopher P. Cannon, Eugene Braunwald, Carolyn H. McCabe, et al.
·
2004
·
New England Journal of Medicine
↗ 4,927
OA
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
Arthur J. Moss, William J. Hall, David S. Cannom, et al.
·
2009
·
New England Journal of Medicine
↗ 3,118
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial
Salim Yusuf, Marc A. Pfeffer, Karl Swedberg, et al.
·
2003
·
The Lancet
↗ 2,968
Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.
Marc A. Pfeffer, Eugene Braunwald
·
1990
·
Circulation
↗ 2,861
OA
Spironolactone for Heart Failure with Preserved Ejection Fraction
Bertram Pitt, Marc A. Pfeffer, Susan F. Assmann, et al.
·
2014
·
New England Journal of Medicine
↗ 2,692
OA
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
John J.V. McMurray, Jan Östergren, Karl Swedberg, et al.
·
2003
·
The Lancet
↗ 2,611
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
Marc A. Pfeffer, John J.V. McMurray, Eric J. Velazquez, et al.
·
2003
·
New England Journal of Medicine
↗ 2,485
OA
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
Scott D. Solomon, John J.V. McMurray, Inder S. Anand, et al.
·
2019
·
New England Journal of Medicine
↗ 2,309
OA
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
Marc A. Pfeffer, Brian Claggett, Rafael Díaz, et al.
·
2015
·
New England Journal of Medicine
↗ 2,309
OA
C-Reactive Protein Levels and Outcomes after Statin Therapy
Paul M. Ridker, Christopher P. Cannon, David A. Morrow, et al.
·
2005
·
New England Journal of Medicine
↗ 2,288
OA